← Evidence map

ArticleTherapeutics and clinical risk management2013

Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD.

Anthony D'UrzoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2013
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23990727